Global Latent Tuberculosis Infection (LTBI) Testing Market Size, Status and Forecast 2019-2025

Published On: Aug 2019

Format: PDF

Publisher: QY Research

Pages: 97

Report ID: 54970

Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.
In 2018, the global Latent Tuberculosis Infection (LTBI) Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Latent Tuberculosis Infection (LTBI) Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Latent Tuberculosis Infection (LTBI) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Qiagen
BioMerieux
Thermo Fisher Scientific
Danaher
Roche
Becton Dickinson
Agilent Technologies
Bio-Rad Laboratories
Eppendorf
Abbott Laboratories

Market segment by Type, the product can be split into
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Others

Market segment by Application, split into
Household Contacts with Pulmonary TB
PLHIV
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Latent Tuberculosis Infection (LTBI) Testing status, future forecast, growth opportunity, key market and key players.
To present the Latent Tuberculosis Infection (LTBI) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Latent Tuberculosis Infection (LTBI) Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Type (2014-2025)
1.4.2 Tuberculin Skin Test (TST)
1.4.3 Interferon Gamma Released Assay (IGRA)
1.4.4 Others
1.5 Market by Application
1.5.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2019-2025)
1.5.2 Household Contacts with Pulmonary TB
1.5.3 PLHIV
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Latent Tuberculosis Infection (LTBI) Testing Market Size
2.2 Latent Tuberculosis Infection (LTBI) Testing Growth Trends by Regions
2.2.1 Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions (2019-2025)
2.2.2 Latent Tuberculosis Infection (LTBI) Testing Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Latent Tuberculosis Infection (LTBI) Testing Market Size by by Players
3.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue by by Players (2014-2019)
3.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by by Players (2014-2019)
3.1.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio (CR5 and HHI)
3.2 Latent Tuberculosis Infection (LTBI) Testing Key Players Head office and Area Served
3.3 Key Players Latent Tuberculosis Infection (LTBI) Testing Product/Solution/Service
3.4 Date of Enter into Latent Tuberculosis Infection (LTBI) Testing Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2014-2019)
4.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2014-2019)

5 North America
5.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
5.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in North America
5.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
5.4 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application

6 Europe
6.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
6.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Europe
6.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
6.4 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application

7 China
7.1 China Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
7.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in China
7.3 China Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
7.4 China Latent Tuberculosis Infection (LTBI) Testing Market Size by Application

8 Japan
8.1 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
8.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Japan
8.3 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
8.4 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
9.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Southeast Asia
9.3 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
9.4 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Application

10 India
10.1 India Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
10.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in India
10.3 India Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
10.4 India Latent Tuberculosis Infection (LTBI) Testing Market Size by Application

11 Central & South America
11.1 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size (2014-2019)
11.2 Latent Tuberculosis Infection (LTBI) Testing Key Players in Central & South America
11.3 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
11.4 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application

12 International Players Profiles
12.1 Qiagen
12.1.1 Qiagen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.1.4 Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019))
12.1.5 Qiagen Recent Development
12.2 BioMerieux
12.2.1 BioMerieux Company Details
12.2.2 Company Description and Business Overview
12.2.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.2.4 BioMerieux Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.2.5 BioMerieux Recent Development
12.3 Thermo Fisher Scientific
12.3.1 Thermo Fisher Scientific Company Details
12.3.2 Company Description and Business Overview
12.3.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.3.4 Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.3.5 Thermo Fisher Scientific Recent Development
12.4 Danaher
12.4.1 Danaher Company Details
12.4.2 Company Description and Business Overview
12.4.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.4.4 Danaher Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.4.5 Danaher Recent Development
12.5 Roche
12.5.1 Roche Company Details
12.5.2 Company Description and Business Overview
12.5.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.5.4 Roche Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.5.5 Roche Recent Development
12.6 Becton Dickinson
12.6.1 Becton Dickinson Company Details
12.6.2 Company Description and Business Overview
12.6.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.6.4 Becton Dickinson Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.6.5 Becton Dickinson Recent Development
12.7 Agilent Technologies
12.7.1 Agilent Technologies Company Details
12.7.2 Company Description and Business Overview
12.7.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.7.4 Agilent Technologies Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.7.5 Agilent Technologies Recent Development
12.8 Bio-Rad Laboratories
12.8.1 Bio-Rad Laboratories Company Details
12.8.2 Company Description and Business Overview
12.8.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.8.4 Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.8.5 Bio-Rad Laboratories Recent Development
12.9 Eppendorf
12.9.1 Eppendorf Company Details
12.9.2 Company Description and Business Overview
12.9.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.9.4 Eppendorf Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.9.5 Eppendorf Recent Development
12.10 Abbott Laboratories
12.10.1 Abbott Laboratories Company Details
12.10.2 Company Description and Business Overview
12.10.3 Latent Tuberculosis Infection (LTBI) Testing Introduction
12.10.4 Abbott Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2014-2019)
12.10.5 Abbott Laboratories Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details